Analysis of gene expressions involved in cancer-host cells cross talk at the invasion front of nonsmall cell lung cancer
非小细胞肺癌侵袭前沿癌症与宿主细胞串扰相关基因表达分析
基本信息
- 批准号:13670192
- 负责人:
- 金额:$ 2.11万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2002
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
It is recently proposed that cancer cells make microenvironment suitable for their invasion through cross talk with host cells. To elucidate genes or molecules involved in the cancer cell-host cell cross talk at the invasion front of nonsmall cell lung cancer (NSCLC), mRNA profilings of 1176 cancer-related genes at the invasion front tissues of NSCLCs of various progressions were analyzed by cDNA macroarray system (Cancer array 1.2, Clontech). 121 genes, including cyclin D1, c-myc, insulin-like growth factor, rho-associated GTP binding proteins, laminin receptor, DNA polymerases, beta-catenin, wnt 8B, elongation factor alpha-1, were commonly overexpressed in NSCLC tissues. Ten genes, such as membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-3, p21-rac1, vascular endothelial growth factor (VEGF), jagged-1, jagged-2, notch-4, c-fos related antigen, were overexpressed both in squamous cell carcinomas and high stage-adenocarcinomas compared with low stage-adenocarcinomas, while ezrin (villin 2) and macrophage inhibitory cytokine (MTC)-1 genes did the opposite. These results were confirmed by real time RT-PCR using TaqMann-probe method. These data suggested that rac-1/MT1-MMP, jagged-1, -2/ notch-4, p53 / MIC-1 groups may actively involved in the cross talk between lung cancer and host cells and works either positively or negatively to make appropriate microenvironment for invasion of the lung cancer cells. We have also established laser-captured microdissection / real time RT-PCR method in order to analyze gene expressions more in detail at the invasion front of NSCLCs. Furthermore, functional and non-invasive examination methods of gene expressions in NSCLC tissues in vivo were tried successfully using FDG- and MIBI-PET. Present results may contribute to estimate biological features of NSCLCs and establish adequate therapy for lung cancer patients.
最近,有人提出,通过与宿主细胞进行串扰,癌细胞使微环境适合其侵袭。为了阐明在nonsmall细胞肺癌的入侵前面参与癌症细胞宿主细胞串扰(NSCLC)的基因或分子,通过CDNA MacroArray System(cancer cancroarray System 1.2,clontech,Clontech)分析了各种进展的NSCLCS的1176个与癌症相关基因的mRNA分析。 121个基因,包括细胞周期蛋白D1,C-MYC,胰岛素样生长因子,RHO相关的GTP结合蛋白,层粘连蛋白受体,DNA聚合酶,β-catenin,Wnt 8b,延长因子Alpha-1在NSCLC组织中通常过表达。十个基因,例如膜型1基质金属蛋白酶(MT1-MMP),MMP-3,P21-RAC1,血管内皮生长因子(VEGF)(VEGF),JAGGED-1,JAGGED-2,JAGGED-2,NOTCH-4,NOTCH-4,C-FOS相关的相关抗原,高度表达了高阶段的高阶段和高级抗原。阶段 - 腺癌,而ezrin(Villin 2)和巨噬细胞抑制细胞因子(MTC)-1基因相反。使用TAQMANN-PROBE方法通过实时RT-PCR证实了这些结果。这些数据表明,RAC-1/ MT1-MMP,JAGGED-1,-2/ NOTCH-4,p53/ MIC-1组可能会积极参与肺癌与宿主细胞之间的串扰,并积极或负面地工作以使适当的微环境侵入肺癌细胞。我们还建立了激光捕获的显微解剖 /实时RT-PCR方法,以便在NSCLCS的入侵方面对基因表达进行更详细的详细分析。此外,使用FDG-和MIBI-PET成功尝试了NSCLC组织中基因表达的功能和非侵入性检查方法。目前的结果可能有助于估计NSCLC的生物学特征,并为肺癌患者建立足够的治疗。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kotaro Higashi et al.: "Value of whole-body FDG PET in management of lung cancer"Ann. Nucl. Med.. 17・1. 1-14 (2003)
Kotaro Higashi 等:“全身 FDG PET 在肺癌治疗中的价值”Ann. 17・1 (2003)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Jinshan Zhou: "Expression of multidrug resistence protein and mRNA correlate with 99mTc-MIBI imaging in patients with lung cancer"J. Nuci. Med.. 42・10. 1476-1483 (2001)
周金山:“肺癌患者中多药耐药蛋白的表达及其与 99mTc-MIBI 成像的相关性”J. Nuci. 1476-1483 (2001)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Jinshan Zhou et al.: "Expression of multidrug resistence protein and mRNA correlate with 99mTc-MIBI imaging in patients with lung cancer"J. Nucl. Med.. 42・10. 1476-1483 (2001)
Jinshan Zhou 等:“肺癌患者中多药耐药蛋白和 mRNA 的表达与 99mTc-MIBI 成像相关”J. Nucl. 1476-1483 (2001)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Jinshan Zhou, Kotaro Higashi, Yoshimichi Ueda, Yuko Kodama, Dachuan Guo, Fumiko Jisaki, Aya Sakurai, Tsutomu Takegami, Shogo Katsuda, and Itaru Yamamoto: "Expression of multidrug resistance protein and messenger RNA correlate with 99mTc-MIBI imaging in pa
Jinshan Zhou、Kotaro Higashi、Yoshimichi Ueda、Yuko Kodama、Dachuanuo、Fumiko Jisaki、Aya Sakurai、Tsutomu Takegami、Shogo Katsuda 和 Itaru Yamamoto:“多药耐药蛋白和信使 RNA 的表达与 99mTc-MIBI 成像相关
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kotaro Higashi, Ichiro Matsunari, Yoshimichi Ueda, Ryosuke Ikeda, Jinfei Guo, Manabu Oguchi, Hisao Tonami and Itaru Yamamoto: "Value of whole-body FDG PET in management of lung cancer."Ann. Nucl. Med.. 17(1). 1-14 (2003)
Kotaro Higashi、Ichiro Matsunari、Yoshimichi Ueda、Ryosuke Ikeda、Jinfeiuo、Manabu Oguchi、Hisao Tonami 和 Itaru Yamamoto:“全身 FDG PET 在肺癌治疗中的价值。”Ann。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
UEDA Yoshimichi其他文献
UEDA Yoshimichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('UEDA Yoshimichi', 18)}}的其他基金
Is sphingolipid of the cell membrane involved in invasion and metastasis of non-adenocarcinoma of the lung?
细胞膜鞘脂是否参与肺非腺癌的侵袭和转移?
- 批准号:
18K07002 - 财政年份:2018
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An approach to free independence based on mutual information
基于互信息的自由独立方法
- 批准号:
16K13762 - 财政年份:2016
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Is sphingolipid of the cell membrane involved in invasion and metastasis of adenocarcinoma of the lung?
细胞膜鞘脂是否参与肺腺癌的侵袭和转移?
- 批准号:
26460442 - 财政年份:2014
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study on von Neumann algebras, free probability and non-commutative function spaces
冯诺依曼代数、自由概率和非交换函数空间的研究
- 批准号:
24540214 - 财政年份:2012
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Involvement and their roles of aquaporins in the metastasis and drug-resistance of bone and soft tissue sarcomas
水通道蛋白在骨软组织肉瘤转移和耐药中的参与及其作用
- 批准号:
22590323 - 财政年份:2010
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study on free probability and operator algebras
自由概率与算子代数研究
- 批准号:
20540213 - 财政年份:2008
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of activation mechanism of HMGA2 gene and its regulating gene-pathways in the progression of lung cancer
HMGA2基因在肺癌进展中的激活机制及其调控基因通路分析
- 批准号:
19590370 - 财政年份:2007
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of activated gene network in the microenvironment of lung cancer-invasion front.
肺癌侵袭前沿微环境激活基因网络分析
- 批准号:
17590320 - 财政年份:2005
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Expression profiling of genes involved in tumor - host stroma cell interaction in the metastasis of human fibrosarcoma cell (HT1080)
人纤维肉瘤细胞(HT1080)转移中涉及肿瘤-宿主基质细胞相互作用的基因的表达谱
- 批准号:
15590322 - 财政年份:2003
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanism of immune escape of human osteosarcoma cells through abnormal expressions of Fas and Fas ligand.
人骨肉瘤细胞通过Fas和Fas配体表达异常的免疫逃逸机制。
- 批准号:
11670198 - 财政年份:1999
- 资助金额:
$ 2.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
幽门螺杆菌感染促进肿瘤相关成纤维细胞与胃癌细胞的互作及机制研究
- 批准号:31760328
- 批准年份:2017
- 资助金额:36.0 万元
- 项目类别:地区科学基金项目
LncRNA-GMAN调控胃癌细胞侵袭和转移的分子作用机制研究
- 批准号:31771540
- 批准年份:2017
- 资助金额:59.0 万元
- 项目类别:面上项目
与肺癌细胞侵袭相关的microRNAs研究
- 批准号:30771187
- 批准年份:2007
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
Non-canonical WNT signaling in the invasion and metastasis of uveal melanoma
葡萄膜黑色素瘤侵袭和转移中的非经典 WNT 信号传导
- 批准号:
9912735 - 财政年份:2017
- 资助金额:
$ 2.11万 - 项目类别:
Patient-oriented Research: Colon CA & Cancer Immunology
以患者为导向的研究:Colon CA
- 批准号:
7251986 - 财政年份:2001
- 资助金额:
$ 2.11万 - 项目类别:
Patient-oriented Research: Colon CA & Cancer Immunology
以患者为导向的研究:Colon CA
- 批准号:
7386702 - 财政年份:2001
- 资助金额:
$ 2.11万 - 项目类别: